Floating Button

The pace of delistings goes on, but 2025 could be a year of IPO revivals (updated)

Samantha Chiew & Nicole Lim
Samantha Chiew & Nicole Lim • 13 min read
The pace of delistings goes on, but 2025 could be a year of IPO revivals (updated)
The STI may be doing well, but companies are finding it hard to list and stay listed in Singapore. Photo: Albert Chua/ The Edge Singapore
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

The Singapore market put up with yet another busy year of delistings, but with better certainty over interest rates, deferred and new listings are on the way

The Singapore market may be one of the top regional performers this year, with the Straits Times Index hitting 17-year highs. However, moribund listing activity and the continuing march of delistings at the same steady pace seen in the last few years have put a dampener on the bourse.

In 1H2024, there was only one IPO. Singapore Institute of Advanced Medicine Holdings (SAM) listed on the Catalist board on Feb 16 at an issue price of 23 cents. On its first day of trading, the counter opened at 19.5 cents down 15.2% from its listing price,  before closing at 19 cents. Its share price has plunged since then. As at Dec 10, shares in SAM closed at 5.8 cents, down about 75% from its issue price.

×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2026 The Edge Publishing Pte Ltd. All rights reserved.